• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

  • About Us
    • About Our Firm
    • Institutional Investor Services
    • KSF in the Community
    • Careers at KSF
    • Contact Us
  • Attorneys
  • Practice Areas
    • Securities Class Action Litigation
    • Corporate Governance And Derivative Litigation
    • Consumer Protection Litigation
    • Shareholder Mergers and Acquisitions Class Action Litigation
    • Antitrust Litigation
  • Current Cases
  • KSF News
  • Client Login
  • Asset Recovery Services
  • Contact KSF

KSF Appointed Lead Counsel in Eletrobas Securities Litigation

Home»News»KSF Appointed Lead Counsel in Eletrobas Securities Litigation

On October 2, 2015, the Hon. John G. Koeltl of the United States District Court for the Southern District of New York entered an Order appointing KSF as lead counsel for the class in the Eletrobras Securities Litigation, Case No. 15-cv-5754-JGK. This matter involves one of the largest kickback corruption schemes in Brazilian history. The complaint alleges that, throughout the Class Period (August 17, 2010 – June 24, 2015), Defendants made materially false and misleading statements to investors concerning the award of contracts for multi-billion dollar construction projects controlled by Eletrobras and its subsidiaries. The Complaint alleges that the award of those contracts was principally the result of bribery and widespread corporate corruption by the Company and the Individual Defendants.

Filed Under: News

Previous Post: « Notice of Settlement of FAB Universal Derivative Litigation
Next Post: Court Denies Motion to Dismiss In Part in In Re Rocket Fuel Securities Litigation »

Primary Sidebar

Current Cases

Cabot Oil & Gas Corporation (NYSE: COG)

Amyris, Inc. (NasdaqGS: AMRS)

Obalon Therapeutics, Inc. (NasdaqGS: OBLN)

Coherent, Inc. (NasdaqGS: COHR)

Penumbra, Inc. (NYSE: PEN)

Anchiano Therapeutics Ltd. (NasdaqGS: ANCN)

see moreĀ»
 

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

© 2006-2021 Copyright. All rights reserved Kahn Swick & Foti LLC · New Orleans · New York — Kahn Swick & Foti LLP · San Francisco

We recently updated our Privacy Policy. We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.OkPrivacy policy